日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learning

基于数字可穿戴鞋垫和机器学习的膝关节病变和步态特征识别

期刊:Elife
影响因子:6.4
doi:10.7554/eLife.86132
Wipperman, Matthew F; Lin, Allen Z; Gayvert, Kaitlyn M; Lahner, Benjamin; Somersan-Karakaya, Selin; Wu, Xuefang; Im, Joseph; Lee, Minji; Koyani, Bharatkumar; Setliff, Ian; Thakur, Malika; Duan, Daoyu; Breazna, Aurora; Wang, Fang; Lim, Wei Keat; Halasz, Gabor; Urbanek, Jacek; Patel, Yamini; Atwal, Gurinder S; Hamilton, Jennifer D; Stuart, Samuel; Levy, Oren; Avbersek, Andreja; Alaj, Rinol; Hamon, Sara C; Harari, Olivier
发表日期：2024
文献求助 收藏

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial

高剂量玻璃体内注射阿柏西普（8毫克）治疗新生血管性年龄相关性黄斑变性患者的疗效：CANDELA II期随机临床试验

期刊:Jama Ophthalmology
影响因子:9.2
doi:10.1001/jamaophthalmol.2023.2421
Wykoff, Charles C; Brown, David M; Reed, Kimberly; Berliner, Alyson J; Gerstenblith, Adam T; Breazna, Aurora; Abraham, Prema; Fein, Jordana G; Chu, Karen W; Clark, W Lloyd; Leal, Sergio; Schmelter, Thomas; Hirshberg, Boaz; Yancopoulos, George D; Vitti, Robert
发表日期：2023
文献求助 收藏

Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain

针对 GFRα3 的单克隆抗体可有效对抗小鼠关节痛模型中诱发的痛觉过敏和异常性疼痛反应，但其中一种抗体 REGN5069 在一项针对骨关节炎疼痛患者的随机安慰剂对照临床试验中对疼痛无效

期刊:Neurobiology of Pain
影响因子:
doi:10.1016/j.ynpai.2023.100136
Selin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, Jutta Miller, Michael LaCroix-Fralish, Veronika Logovinsky, Yamini Patel, Richard Torres, Samit Ganguly, Aurora Breazna, Michelle DeVeaux, Rafia Bhore, Min Gao, Frank J Delfino, Ashique Rafique, Jeanette L Fairhurst, Charleen Hunt, Robert
免疫
关节炎
发表日期：2023
文献求助 收藏

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors

在针对晚期实体瘤患者的 I 期研究中，采用药效学指导的 PF-00337210 剂量选择

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-016-2958-1
Bruce, Justine Yang; LoRusso, Patricia M; Goncalves, Priscila H; Heath, Elisabeth I; Sadowski, Elizabeth; Shalinsky, David R; Zhang, Yanwei; Traynor, Anne M; Breazna, Aurora; Ricart, Alejandro D; Tortorici, Michael; Liu, Glenn
发表日期：2016
文献求助 收藏

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

伊立替康联合替莫唑胺（TEMIRI）治疗复发或难治性髓母细胞瘤患儿的II期研究：一项ITCC和SIOPE联合开展的脑肿瘤研究

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/not097
Grill, Jacques; Geoerger, Birgit; Gesner, Lyle; Perek, Danuta; Leblond, Pierre; Cañete, Adela; Aerts, Isabelle; Madero, Luis; de Toledo Codina, Josep Sanchez; Verlooy, Joris; Estlin, Edward; Cisar, Laura; Breazna, Aurora; Dorman, Andrew; Bailey, Simon; Nicolin, Gary; Grundy, Richard G; Hargrave, Darren
细胞生物学
肿瘤
肿瘤免疫
神经科学
发表日期：2013
文献求助 收藏

Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)

阿托伐他汀治疗后肾小球滤过率估计值的改善与心力衰竭住院率降低之间的关系（来自“治疗至新目标”[TNT]研究）

期刊:American Journal of Cardiology
影响因子:2.1
doi:10.1016/j.amjcard.2012.02.019
Ho, Jennifer E; Waters, David D; Kean, Allison; Wilson, Daniel J; Demicco, David A; Breazna, Andrei; Wun, Chuan-Chuan; Deedwania, Prakash C; Khush, Kiran K
心力衰竭
心血管
发表日期：2012
文献求助 收藏

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

塞来昔布预防腺瘤试验的五年疗效和安全性分析

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-08-0206
Bertagnolli, Monica M; Eagle, Craig J; Zauber, Ann G; Redston, Mark; Breazna, Aurora; Kim, Kyungmann; Tang, Jie; Rosenstein, Rebecca B; Umar, Asad; Bagheri, Donya; Collins, Neal T; Burn, John; Chung, Daniel C; Dewar, Thomas; Foley, T Raymond; Hoffman, Neville; Macrae, Finlay; Pruitt, Ronald E; Saltzman, John R; Salzberg, Bruce; Sylwestrowicz, Thomas; Hawk, Ernest T
发表日期：2009
文献求助 收藏

The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study

对收缩压正常或偏高的稳定型冠心病患者进行强化降脂治疗的益处：一项“治疗至新目标”（TNT）研究的分析

期刊:Journal of Clinical Hypertension
影响因子:2.5
doi:10.1111/j.1751-7176.2008.07851.x
Kostis, John B; Breazna, Andrei; Deedwania, Prakash C; LaRosa, John C
心血管
冠心病
发表日期：2008
文献求助 收藏